| A Study to Evaluate Mesenchymal Stem Cell Product StromaForte's Effect on Cardiovascular Events (NCT06087848) | Cellcolabs Clinical LTD. | 2023-10-07 |
| A Study to Evaluate the Mass Balance of [14C]SHR2554 in Healthy Adult Volunteers (NCT06010680) | Jiangsu HengRui Medicine Co., Ltd. | 2023-10-07 |
| Minimally-invasive Stabilization of Pelvic Metastases With Photodynamic Nails: A Multi-center Prospective Study of Functional Outcome (NCT06083896) | M.D. Anderson Cancer Center | 2023-10-06 |
| A Study of MDI-1228_mesylate Ophthalmic Solution in Healthy Adults (NCT05969236) | Shanghai Medinno Pharmaceutical Technology Co., Ltd. | 2023-10-06 |
| A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors. (NCT05977322) | Novartis Pharmaceuticals | 2023-10-06 |
| Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma (NCT06049576) | City of Hope Medical Center | 2023-10-06 |
| A Study to Determine the Tolerability of Intranasal LMN-301 (NCT06030414) | Lumen Bioscience, Inc. | 2023-10-06 |
| A Study to Test How Well Different Doses of BI 771716 Are Tolerated by People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy (NCT06006585) | Boehringer Ingelheim | 2023-10-06 |
| Dampening the Reproductive Axis With Continuous Kisspeptin (NCT05971849) | Stephanie B. Seminara, MD | 2023-10-06 |
| A Proof of Concept Study to Evaluate Exosomes From Human Mesenchymal Stem Cells in Women With Premature Ovarian Insufficiency (POI) (NCT06072794) | Vitti Labs, LLC | 2023-10-06 |
| Safety, Reactogenicity, and Immunogenicity Study of a Self-Amplifying MRNA Influenza Vaccine in Healthy Adults (NCT06028347) | Seqirus | 2023-10-05 |
| To Evaluate the Safety and Pharmacokinetic Characteristics After Multiple Administration of JC-013 and JLP-2004 (NCT06169059) | Jeil Pharmaceutical Co., Ltd. | 2023-10-05 |
| A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors (NCT05941507) | LigaChem Biosciences, Inc. | 2023-10-05 |
| SGLTi, Hepatic Glucose Production and Ketogenesis (NCT05960656) | The University of Texas Health Science Center at San Antonio | 2023-10-05 |
| Study of the Safety, Tolerability, and Pharmacokinetics of LV232 Capsules in Chinese Healthy Volunteers (NCT06070857) | Vigonvita Life Sciences | 2023-10-05 |
| HNC: Human Neural Circuits Electrophysiology During Cognition (NCT05962424) | Stanford University | 2023-10-05 |
| A Study About Fazirsiran in People With and Without Liver Problems (NCT05891158) | Takeda | 2023-10-05 |
| TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL) (NCT06106841) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2023-10-05 |
| A Study to Assess Food Effect of Venetoclax New Tablet Formulation in Healthy Female Participants (NCT06070948) | AbbVie | 2023-10-05 |
| A Study to Evaluate the Relative Bioavailability of Subcutaneous Bepirovirsen When Delivered From a Vial or Prefilled Syringe Fitted With a Safety Syringe Device in Healthy Adult Participants (NCT06058390) | GlaxoSmithKline | 2023-10-04 |
| Phase I/II Study of JR-441 in Patients With Mucopolysaccharidosis Type IIIA (NCT06095388) | JCR Pharmaceuticals Co., Ltd. | 2023-10-04 |
| A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas (NCT05934838) | Weill Medical College of Cornell University | 2023-10-04 |
| Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With Hyperuricemia (NCT06056570) | Urica Therapeutics Inc. | 2023-10-04 |
| Single Ascending Dose, Multiple Ascending Dose, Food Effect Study With AP31969 (NCT06066099) | Acesion Pharma | 2023-10-04 |
| KET-RO Plus RO DBT for Treatment Resistant Depression (NCT06138691) | Washington University School of Medicine | 2023-10-04 |
| Investigation of Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-6856 in Healthy Participants, Including a Subset of Healthy Japanese Participants (NCT06069895) | Novo Nordisk A/S | 2023-10-04 |
| Single Center Study Of N-803 Stimulation On Expansion, Enrichment, Proliferation Of Natural Killer Cells Collected By Apheresis (NCT06040918) | ImmunityBio, Inc. | 2023-10-04 |
| Polatuzumab Vedotin (Pola) Plus Rituximab (R) in Patients With Post-transplant Lymphoproliferative Disorder (PTLD) (NCT06040320) | Washington University School of Medicine | 2023-10-04 |
| Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer (NCT05945875) | Vanderbilt-Ingram Cancer Center | 2023-10-03 |
| Food Effect Study of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia (NCT06036108) | Otsuka Pharmaceutical Co., Ltd. | 2023-10-03 |
| GDNF Gene Therapy for Multiple System Atrophy (NCT04680065) | Brain Neurotherapy Bio, Inc. | 2023-10-03 |
| Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resistant Tuberculosis (NCT05586230) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-10-03 |
| Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route (NCT06126042) | Dr. Reddy's Laboratories Limited | 2023-10-03 |
| A First-in-Human Study Evaluating AGA2115 in Adult Healthy Volunteers (NCT06086613) | Angitia Incorporated Limited | 2023-10-03 |
| A Study of DISC-3405 in Healthy Volunteers (NCT06050915) | Disc Medicine, Inc | 2023-10-03 |
| The Safety and Dosimetry Study of 177Lu-LNC1004 Injection (NCT05723640) | Yantai LNC Biotechnology Singapore PTE. LTD. | 2023-10-03 |
| Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma (NCT06050512) | Kathleen Dorritie | 2023-10-02 |
| Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic Leukemia (NCT05993949) | Stanford University | 2023-10-02 |
| A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors (NCT05892718) | FBD Biologics Limited | 2023-10-02 |
| Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM) (NCT06087653) | Starton Therapeutics, Inc | 2023-10-02 |
| A Study of onCARlytics (CF33-CD19) in Combination With Blinatumomab in Adults With Advanced or Metastatic Solid Tumors (OASIS) (NCT06063317) | Imugene Limited | 2023-10-02 |
| Tafasitamab, Acalabrutinib, and Obinutuzumab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (NCT05943496) | OHSU Knight Cancer Institute | 2023-10-02 |
| A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010 (NCT05867121) | Genentech, Inc. | 2023-10-02 |
| Targeting Androgen Signaling in Urothelial Cell Carcinoma - Neoadjuvant (NCT05839119) | Brown University | 2023-10-02 |
| Concentration-QT Study of Paroxetine in Healthy Adults (NCT06065735) | GlaxoSmithKline | 2023-10-02 |
| A Study of Multiple-ascending Doses of GSBR-1290 in Healthy Overweight/Obese Participants (NCT06139055) | Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics | 2023-10-02 |
| A Study to Evaluate the Effect of Food on Nemtabrutinib (MK-1026) in Healthy Participants (MK-1026-017) (NCT06772818) | Merck Sharp & Dohme LLC | 2023-10-02 |
| Alexithymia Intervention for Suicide (NCT05724953) | VA Office of Research and Development | 2023-10-01 |
| BC3402 in Combination With Durvalumab in Patients With Advanced Hepatocellular Carcinoma (NCT06111326) | Biocity Biopharmaceutics Co., Ltd. | 2023-10-01 |
| A Dose Escalation Study of Intensity Modulated Total Marrow Irradiation (IMRT-TMI) Followed by Fludarabine as a Myeloablative Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed and Refractory Hematologic Malignancies (NCT05201183) | Naoyuki G. Saito, M.D., Ph.D. | 2023-10-01 |
| Gene Therapy for Post-Operative Atrial Fibrillation (NCT05223725) | University of Massachusetts, Worcester | 2023-10-01 |
| Treatment of Tinnitus With Olanzapine (NCT07190482) | University of Sao Paulo | 2023-10-01 |
| Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects (NCT06062680) | Jiangsu HengRui Medicine Co., Ltd. | 2023-10-01 |
| Efficacy and Safety of CD19CD20-CAR.p40-T in B-cell Lymphoma (NCT07097207) | Shenzhen University General Hospital | 2023-10-01 |
| Investigating the Efficacy of Autologous, Adipose-derived Mesenchymal Stem Cell Therapy for the Treatment of Sexual Function Impairment in Women Aged 40-50 (NCT06726538) | Vinmec Research Institute of Stem Cell and Gene Technology | 2023-10-01 |
| Gemox Combined With Anlotinib and Sintilimab in Advanced cHCC-ICC (NCT06033118) | Sichuan University | 2023-10-01 |
| HEM-iSMART-A: Decitabine / Venetoclax and Navitoclax in Pediatric Patients With Relapsed or Refractory Hematological Malignancies (NCT05740449) | Princess Maxima Center for Pediatric Oncology | 2023-10-01 |
| Proglumide With Gemcitabine and Nab-Paclitaxel in PatientsWith Metastatic Pancreatic Ductal Adenocarcinoma (NCT06017323) | Georgetown University | 2023-10-01 |
| Open-Label Dose-Ranging Study of Oral SM-001 in Healthy Adults (NCT05894902) | Advanced Integrative Medical Science Institute | 2023-10-01 |
| A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL (NCT06547528) | Ono Pharmaceutical Co., Ltd. | 2023-10-01 |
| A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors (NCT06041035) | Qilu Pharmaceutical Co., Ltd. | 2023-10-01 |
| 68Ga-P16-093 PET/CT Imaging in the Salivary Gland (NCT06049368) | Peking Union Medical College Hospital | 2023-10-01 |
| A Study to Observe and Evaluate the Safety and Efficacy of c610 Injection for Treatment of Advanced Solid Tumor Patients (NCT06082570) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2023-10-01 |
| A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor Patients (NCT06082557) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2023-10-01 |
| Epigenetic Memory of Vitamin D Supplementation (NCT06104111) | Polish Academy of Sciences | 2023-10-01 |
| 1% Acetic Acid vs Normal Saline Dressing inManagement of Diabetic Foot (NCT06356480) | Dr. Muhammad Naeem | 2023-10-01 |
| Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata. (NCT06087796) | Assiut University | 2023-10-01 |
| Non-operative vs. Operative Management of Acute Appendicitis in Vulnerable Patient Populations (NCT05724628) | University of Texas Southwestern Medical Center | 2023-10-01 |
| A Dose Escalation and Expansion Study of NB002 in Participants With Advanced or Metastatic Solid Tumors (NCT05924906) | Suzhou Neologics Bioscience Co., Ltd. | 2023-10-01 |
| Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation (NCT06045364) | Jie Chen | 2023-10-01 |
| A Study of QL1706H in Patients With Advanced Solid Tumors (NCT06047431) | Qilu Pharmaceutical Co., Ltd. | 2023-10-01 |
| Phase I Clinical Study of HRS-9815 for PET/CT Imaging in Patients With Prostate Cancer (NCT06062355) | Jiangsu HengRui Medicine Co., Ltd. | 2023-10-01 |
| Safety, Efficacy, and Dosing of VIX001 in Patients With Neurological Symptoms of Post Acute COVID-19 Syndrome (PACS). (NCT05947617) | Neobiosis, LLC | 2023-10-01 |
| Group MDMA-therapy for Veterans With PTSD (NCT05961527) | Portland VA Research Foundation, Inc | 2023-10-01 |
| A Trial of HRS-7450 in Chinese Healthy Volunteers (NCT06087094) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2023-10-01 |
| Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue (NCT05751720) | Dr Adnan Agha | 2023-10-01 |
| Repeat Intravenous Infusions of B4T2-001 CAR-T Without Lymphodepleting Chemotherapy for Solid Tumors (NCT06072989) | Shanghai East Hospital | 2023-10-01 |
| Dalpiciclib Isethionate Tablets Combined With Abiraterone Acetate Tablets (I) and Prednisone Tablets (AA-P) Versus Placebo Combined With AA-P in Treatment of High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC) (NCT06099990) | Jiangsu HengRui Medicine Co., Ltd. | 2023-10-01 |
| Project SHINE (Sleep Health INitiative for Equity): Culturally Informing a Sleep Extension Intervention for African American Adults (NCT06226077) | University of Minnesota | 2023-10-01 |
| A First-in-human of Multiplle Doses of BB-1709 in Subjects With Locally Advanced/Metastatic Solid Tumors (NCT06241898) | Bliss Biopharmaceutical (Hangzhou) Co., Ltd | 2023-10-01 |
| A Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patients With Advanced Solid Tumors (NCT06092268) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2023-10-01 |
| Delayed Tolerance Through Mixed Chimerism (NCT05900401) | Massachusetts General Hospital | 2023-10-01 |
| Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG (NCT05610891) | Cellectar Biosciences, Inc. | 2023-10-01 |
| Effect of Kinesio Tape Versus Systemic Dexamethasone on Postsurgical Sequels Following Extraction of Impacted Mandibular Third Molars (NCT07353593) | Ashraf elanzy | 2023-10-01 |
| Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer (NCT06006104) | Jiangsu HengRui Medicine Co., Ltd. | 2023-09-30 |
| Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of Acute-on-Chronic Liver Failure (NCT05985863) | Beijing 302 Hospital | 2023-09-30 |
| Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors (NCT06010862) | Chongqing Precision Biotech Co., Ltd | 2023-09-30 |
| Tris-CAR-T Cell Therapy for Recurrent Glioblastoma (NCT05577091) | Beijing Tiantan Hospital | 2023-09-30 |
| DV Combined With PD-1 and Platinum-based First-line Treatment in Patients With HER2 IHC2+/3+ ESCC (NCT06055153) | Changhai Hospital | 2023-09-30 |
| MSC-EV in Acute-on-Chronic Liver Failure After Liver Transplantation (NCT05881668) | Third Affiliated Hospital, Sun Yat-Sen University | 2023-09-30 |
| Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) for the Treatment of Intermediate or High Grade B-Cell Non-Hodgkin Lymphoma (NCT05801913) | City of Hope Medical Center | 2023-09-29 |
| A Study in Healthy Men to Test Whether Itraconazole Influences the Amount of BI 1584862 in the Blood (NCT06041438) | Boehringer Ingelheim | 2023-09-29 |
| Tomivosertib in Relapsed or Refractory Acute Myeloid Leukemia (AML) (NCT05744739) | Northwestern University | 2023-09-29 |
| Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness (NCT06110403) | University Hospital, Lille | 2023-09-29 |
| Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities (NCT05619211) | University of Alabama at Birmingham | 2023-09-29 |
| A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and Overweight (NCT06151964) | AstraZeneca | 2023-09-29 |
| First in Human Study of TORL-3-600 in Participants With Advanced Cancer (NCT05948826) | TORL Biotherapeutics, LLC | 2023-09-29 |
| JAK/STAT Inhibition in CNS Kohlmeier-Degos Disease (NCT05998395) | National Heart, Lung, and Blood Institute (NHLBI) | 2023-09-28 |
| A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies (NCT05957367) | Deciphera Pharmaceuticals, LLC | 2023-09-28 |
| A Study of YL-17231 in Patients With Advanced Solid Tumors (NCT06078800) | Shanghai YingLi Pharmaceutical Co. Ltd. | 2023-09-28 |